High prevalence of liver fibrosis among general population: a Romanian population-based study-Reference-Cited by-同舟云学术

High prevalence of liver fibrosis among general population: a Romanian population-based study

Published:2023-01-18 Issue:2 Volume:7 Page:e0032-e0032
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:

Author:

Trifan Anca,Muzica Cristina-Maria,Nastasa Robert,Zenovia Sebastian,Stratina Ermina,Stafie Remus,Rotaru Adrian,Singeap Ana-Maria,Cojocariu Camelia,Sfarti Catalin,Girleanu Irina,Chiriac Stefan,Cuciureanu Tudor,Huiban Laura,Stanciu Carol

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Reference44 articles.

1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017;Roth;Lancet,2018

2. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet Gastroenterol Hepatol,2020

3. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study;Fleming;Liver Int,2012

4. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases;Ginès;Hepatology,2022

5. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-invasive Serological Markers of Hepatic Fibrosis – Mini Review;Archives of Surgery and Clinical Research;2024-05-14

2. Macrophages and platelets in liver fibrosis and hepatocellular carcinoma;Frontiers in Immunology;2023-12-05

3. Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β;EJNMMI Radiopharmacy and Chemistry;2023-09-21

4. STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations;Pharmaceuticals;2023-07-28

5. High prevalence of liver fibrosis among general population: a Romanian population-based study: Erratum;Hepatology Communications;2023-02